Waiver, payment deadlines extended for Tricare West Region
Beneficiaries now have until April 30 to use referral approval waivers and point-of-service waivers and provide payment information to TriWest, the agency announced Thursday. The previous deadline was March 31.
Officials have extended these deadlines as West Region beneficiaries and health care providers have reported a number of problems with the contract transition from Health Net Federal Services to TriWest. TriWest officials have said they're taking steps to improve their online portals and staffed up their customer call centers to provide more service to beneficiaries and health care providers.
Referral approval waiver: This allows Tricare Prime beneficiaries to seek care with Tricare-approved specialists, with referrals from their primary care managers, without having to go through TriWest to get those referrals approved.
Beneficiaries may seek outpatient care from these specialists with a copy of their primary care manager's referral dated between Jan. 1 and April 30 and a copy of the Tricare West Region referral/authorization waiver approval letter.
Some families have told Military Times that even with the referral waiver, some specialists won't see Tricare patients because of various issues they've been having.
The referral waiver doesn't apply to inpatient care, applied behavior analysis, Autism Care Demonstration services, laboratory-developed tests and Extended Care Health Option services.
Point-of-service waiver: This allows Tricare Prime beneficiaries in the West Region to continue seeing providers who may no longer be in the Tricare network after the contract transition. The provider must be Tricare authorized, which means they meet certain requirements. Those using the point-of-service waiver through April 30 will pay regular Tricare Prime co-pays, instead of the more costly point-of-service fees. Using the point-of-service option doesn't require a referral.
Tricare snafus cause medical shortfalls for military families
Payment extension: The extension for setting up payments applies to certain beneficiaries in the West Region who pay fees for their Tricare Prime or Tricare Select plans and those who are enrolled in a premium-based plan, including Tricare Young Adult, Tricare Reserve Select and Tricare Retired Reserve.
Those who paid their fees to the previous contractor using electronic funds transfer, credit card or debit card must contact TriWest to set up the payment using one of those methods. Some beneficiaries have experienced difficulties setting up those payments through the TriWest portal and customer call center, Military Times previously reported. Tricare officials have said those who paid previously by allotment didn't have to take action because their allotment would be automatically ported over. Some beneficiaries told Military Times this didn't happen for them.
Defense Health Agency officials, who have extended this deadline several times, warn beneficiaries could be disenrolled from Tricare, retroactive to Jan. 1, if they fail to set up their payments by April 30.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
an hour ago
- Newsweek
'Beware' Mousse-Based Sunscreen, FDA Warns
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. While some sunscreens may look more appealing than others, the jury is now out on whether certain types do what they say on the bottle. The Food and Drug Administration (FDA) has issued a warning to "beware" sunscreen products that come in mousse form because they might not be effective. The federal agency has sent warning letters to five companies marketing sunscreen products in mousse-style—including brands Supergoop!, Vacation Inc., Kalani Sunwear, Botao Baby and Tizo Skin—and citing efficacy concerns, regulatory violations and packaging risks. Some companies are already pulling products from their U.S. sites, such as Kalani Sunwear. Woman applying sunscreen on man's face outdoors. Woman applying sunscreen on man's face outdoors. JordiThe FDA's letter to Supergoop!, for example, reads in part: "This letter is to advise you that on May 2nd, 2025 the U.S. Food and Drug Administration (FDA) reviewed your product labeling, including your website, where your 'Supergoop! PLAY SPF 50 BODY MOUSSE' drug product is available for purchase in the United States without a prescription." It said that based on their labeling—e.g. "Broad Spectrum Sunscreen SPF 50" and "Helps prevent sunburn..."—it is intended for use as an over-the-counter (OTC) sunscreen drug product, but no FDA-approved relevant application is in effect for this. On X, the FDA also warned: "Some mousse sunscreen products resemble whipped cream containers and may put consumers at risk if ingested." Beware of sunscreen products in mousse form because they might not be effective. The FDA issued five warning letters to companies marketing sunscreen products in mousse form: — FDA Drug Information (@FDA_Drug_Info) August 12, 2025 In light of this, Newsweek spoke to dermatologist professor Adam Friedman of the George Washington University about what the FDA warning means for Americans' sunscreen routines and how to choose safe and effective protection. "Sunscreens are OTC drugs, which distinguishes them from a moisturizer or a cosmeceutical. It means the regulation, the expectation in terms of efficacy, how well it works and safety is going to be different," Friedman explained. "But also what it relates to is not just the active ingredient, but the formulation—and that's where the whole mess comes in. "As of right now, under the 'monograph'—the umbrella of what is considered a sunscreen—oils, creams, lotions, gels, butters, pastes, ointments, powders, sprays and sticks fall under the category. Mousses and foams do not." Efficacy and safety are then a separate issue. "A mousse or a foam are aerated, and therefore how they interface with the skin when you rub them on may be very different from a cream or a spray or a stick," said Friedman. "We don't know if, based on that formulation, your UV filters—whether mineral or chemical—are going to behave the same way in the approved formulations. We can't guarantee that these mousse formulation sunscreens will actually work, let alone guarantee their safety." While Friedman said it is "concerning" some brands have not followed the correct process he hopes they were "trying to provide more options to hopefully ensure everyone is using a sun protection product". Smiling woman applying sunscreen on her face while looking in mirror in her bathroom. Smiling woman applying sunscreen on her face while looking in mirror in her bathroom. Ridofranz/Getty Images When deciding how to pick out the best sunscreen, Friedman advises going with the path of least risk. "That's going to be the sunscreens that do follow the monograph," he urged. "I tend to also say, go with the larger brand companies, because they have the size, wherewithal and resources to actually study their products. Not just ensure they meet FDA guidelines, but they'll do clinical studies to look at tolerability, cosmesis [preservation of appearance] and even the effect of these sunscreens on other things. "We use sunscreen not just to protect against skin cancer, but also accelerated skin aging and skin discoloration." Friedman said finding one that's right for you is still important. "Take these tried and true brands and do patch testing to see A) does your skin tolerate it and B) does it rub in well so you're not walking around with a white or purple cast. Samples from the dermatology office are so helpful." He recommends wearing at least an SPF 30 or higher each day. "I tend to say 50, not because there's such a huge delta between 30 and 50—and you will never 100 percent block UV radiation—but because these numbers are based on the FDA approach to measuring efficacy," Friedman said. While it's based on a set concentration of two milligrams of sunscreen per centimeter square of skin, most people don't put that much on. "The higher SPFs are good because it takes into account human error," he added. "With how much people are actually applying, a 70 ends up being a 40 and a 50 ends up being 30. "So in an ideal world: SPF, 30, maybe 50, broad spectrum, water resistant to 80 minutes. Then it's about what plays nice on your skin." Friedman himself wears sunscreen all year round, even in winter. "Every day to exposed areas. Do you brush your teeth every day? Sunscreen is the brushing the teeth of the skin. We brush our teeth to protect the integrity and health of our teeth. Applying sunscreen is the exact same thing." He also emphasized sunscreen is just one protection factor that should be used alongside wearing hats, sunglasses, the right clothing, seeking shade during peak hours and being fully aware. This includes knowing that windows won't block out UVA (while this will less likely cause burning, it can increase the risk of accelerated skin aging because it penetrates deeper). Supergoop! told Newsweek: "At Supergoop! we remain committed to innovation in sun care and the highest standards of product efficacy and safety. The recent communication from the FDA regarding our PLAY SPF 50 Body Mousse is focused on product labeling and has nothing to do with its safety, effectiveness, or formula. We are working closely with the FDA to resolve this matter as we continue to uphold the high standards our consumers expect from us." Vacation Inc told Newsweek: "At Vacation Sunscreen, we take regulatory compliance seriously and appreciate the opportunity to address the U.S. Food and Drug Administration's recent Warning Letter. We have full confidence in the safety, efficacy, and integrity of our product. We are committed to working collaboratively with the FDA to satisfactorily resolve this matter." Kalani Sunwear told Newsweek:"Kalani Sunwear acknowledges receipt of the FDA letter and has voluntarily paused sales in the U.S. while we review the administrative requirements. Importantly, the letter relates to regulatory classification only—not to the safety or efficacy of our SPF 50 mousse. Our formula is manufactured in Sweden, independently tested to EU standards, and uses advanced UV filters that are not yet approved in the U.S. (the FDA has not approved a new UV filter since 1999). We remain fully compliant with European regulations and stand by the quality and effectiveness of our product." Newsweek has also reached out to Botao Baby, Tizo Skin and the FDA for comment. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about sunscreen? Let us know via health@
UPI
5 hours ago
- UPI
FDA approves use of animal drugs to treat New World Screwworm
The Food and Drug Administration is seeking to prevent possible infestations of the New World Screwworm by authorizing the use of animal drugs. File Photo by Juan Manuel Blanco/EPA-EFE Aug. 20 (UPI) -- The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New World Screwworm, which poses an emerging threat to U.S. livestock and food security. The parasite infests warm-blooded animals and in rare cases humans, causing tissue damage and occasionally death. Though eradicated in both North and Central America a decades ago, the screwworm has progressed north since 2022 and is nearing the U.S. southern border. The U.S. Department of Health and Human Services said it issued a declaration on Tuesday allowing the FDA to issue emergency use authorizations for animal drugs to prevent infestations. "Today, we are taking decisive action to safeguard the nation's food supply from this emerging threat," HHS Secretary Robert F. Kennedy Jr. said in a statement. "This authorization equips FDA to act quickly, limit the spread of New World Screwworm and protect America's livestock." Endemic to Cuba, Haiti, Dominican Republic and the countries of South America, the New World Screwworm strikingly resembles a fly, but when in its larval stage it burrows into the flies of a living animals, such as livestock, the U.S. Department of Agriculture said. The United States has worked with Panama for decades to prevent the parasite's northward expansion, according to the USDA, which resulted in the eradication of the insect from the United States in 1966. There are no FDA-approved drugs for NWS, but through an Emergency Use Authorization, the FDA can permit the use of certain animal drug products that have been approved for other purposes or are available in other countries. "This emergency use authorization is another tool we can use in the fight against New World Screwworm," Agriculture Secretary Brooke Rollins said. "Our cattle ranchers and livestock producers are relying on the Trump administration to defend their livelihoods. Stopping this pest is a national security priority and we are linking arms across President [Donald] Trump's Cabinet to defend our borders and push back this threat."
The Hill
a day ago
- The Hill
HHS will allow emergency use of animal drugs in New World screwworm fight
The Food and Drug Administration (FDA) became authorized on Tuesday to allow the use of animal drugs to treat or prevent infestations caused by the New World screwworm, a flesh-eating parasite that has recently disrupted the cattle industry. A declaration from the Department of Health and Human Services (HHS) will allow the FDA to issue emergency use authorizations for animal drugs to treat the insect. A spokesperson for HHS did not specify what medicines have been green-lit to combat the parasite. 'Our priority is to safeguard both animal health and the nation's food supply,' said FDA Commissioner Marty Makary. ' FDA is acting swiftly and responsibly to help ensure we have the necessary tools to prevent and control New World Screwworm, minimizing risks to agriculture and public health.' New World screwworms are a type of fly that lay their eggs in warm-blooded animals like cattle, horses, deer and even household pets like cats and dogs, according to the Department of Agriculture (USDA). Once the eggs hatch, the larvae can cause deadly damage to animals as they burrow into open wounds to feed on living tissue. In rare cases, the bugs have been known to attack humans, but HHS said in a statement that the current risk to human health in the U.S. 'remains very low.' But the potential future threat to animals and the country's food supply chain requires proactive action. USDA announced in May it would suspend all cattle, horse, and bison imports from Mexico after the bug was detected about 700 miles from the U.S. border in animals in Oaxaca and Veracruz. There are no FDA-approved drugs to treat the parasite in the U.S., but the agency can authorize the 'flexible, faster use' of certain animal drug products approved for other purposes or available in other countries under an emergency use authorization, according to a statement from HHS. 'Stopping this pest is a national security priority and we are linking arms across President Trump's cabinet to defend our borders and push back this threat,' said Agriculture Secretary Brooke L. Rollins.
